SCHEMBL24310019

SCHEMBL24310019

CCc1c(Cl)nc(NSc2cnn(C)c2)nc1Oc1ccc(N2CCNCC2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 4/20 0.39
▸ HTR3E A5X5Y0 2/20 0.34
▸ HTR3B O95264 2/20 0.34
▸ ADRB1 P08588 2/20 0.34
▸ HTR3A P46098 2/20 0.34
▸ HTR3D Q70Z44 2/20 0.34
▸ HTR3C Q8WXA8 2/20 0.34
▸ SIGMAR1 Q99720 2/20 0.34
▸ ACVR1 Q04771 2/20 0.33
▸ CETP P11597 2/20 0.32
▸ RET P07949 1/20 0.32
▸ CCNB2 O95067 1/20 0.32
▸ CCNE2 O96020 1/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ CDK4 P11802 1/20 0.32
▸ CCNB1 P14635 1/20 0.32
▸ CCNA2 P20248 1/20 0.32
▸ CCND1 P24385 1/20 0.32
▸ CCNE1 P24864 1/20 0.32
▸ CDK2 P24941 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309498 0.85 ACVR1 (0.32) LTA4HHTR3EHTR3BADRB1HTR3A
SCHEMBL24310026 0.85 ACVR1 (0.32) LTA4HHTR3EHTR3BADRB1HTR3A
SCHEMBL24310025 0.83 TNK2 (0.35) LTA4HACVR1RETCCNB2CCNE2
SCHEMBL24310046 0.83 LTA4H (0.34) LTA4HACVR1CDK1CDK4CCNB1
SCHEMBL29566691 0.82 LTA4H (0.38) LTA4HHTR3EHTR3BADRB1HTR3A
SCHEMBL24309487 0.82 LTA4H (0.38) LTA4HHTR3EHTR3BADRB1HTR3A
SCHEMBL24310033 0.81 LTA4H (0.32) LTA4HACVR1RETCCNB2CCNE2
SCHEMBL24309743 0.80 LTA4H (0.41) LTA4HHTR3EHTR3BADRB1HTR3A
SCHEMBL24309744 0.77 LTA4H (0.38) LTA4HHTR3EHTR3BADRB1HTR3A
SCHEMBL24309527 0.75 DRD2 (0.39) EGFRBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback